Cellebrite in the news

Cellebrite DI Ltd. reported strong ARR and subscription growth, improved profitability, and strategic expansion in defense and intelligence sectors despite federal challenges and acquisition delays.

Cellebrite DI Ltd. is listed on NASDAQ with live stock quotes, and a trading bootcamp is promoted to help traders improve.

Cellebrite's stock jumped over 20% after reporting better-than-expected Q3 earnings and raising full-year revenue guidance.

Cellebrite's Q3 earnings beat expectations with strong revenue growth and U.S. federal business momentum, boosted by a strategic acquisition.

Cellebrite reported strong Q3 2025 financial results with 18% revenue growth driven by U.S. Federal demand and new product innovations.

Cellebrite DI Ltd. beat Q3 earnings and revenue estimates but its stock has declined year-to-date and holds a hold rating.

Cellebrite’s Q3 2025 results beat expectations with strong revenue growth, rising subscription sales, and positive analyst outlook driven by public sector demand and product innovation.

Cellebrite reported strong Q3 results with significant subscription revenue growth and raised its 2025 revenue guidance.

Cellebrite reported strong Q3 2025 financial results and launched new AI-driven digital investigation tools, with growth expected in the U.S. Federal sector.

Cellebrite posted strong Q3 2025 financial results with 19% ARR growth, solid profitability, reaffirmed 2025 targets, and announced new product launches and leadership hires.

Cellebrite is positioned to benefit from AI and favorable U.S. legislation, supporting its specialized product suite.

Cellebrite's stock has dropped recently amid high valuation concerns, but analysts see potential upside from AI innovation and acquisitions despite risks from federal contract reliance.

Cellebrite DI's stock rating was downgraded to hold amid mixed analyst opinions despite recent earnings beat and revenue growth.

Ameren and Cellebrite appoint new general counsels, with Cellebrite hiring Holly Windham to lead legal and compliance functions amid leadership changes.

Institutional investors adjusted their holdings in Cellebrite DI amid mixed analyst ratings, while the company reported better-than-expected Q2 earnings and continues to grow revenue.

Cellebrite appointed Holly Windham as General Counsel to lead legal and compliance efforts amid global expansion, leveraging her extensive tech and cybersecurity legal experience.

Cellebrite appointed a new general counsel and chief compliance officer from Self Financial to enhance its legal and compliance team.

Leaked Cellebrite data reveals that Google Pixel phones running GrapheneOS significantly resist forensic data extraction, especially before first unlock, complicating law enforcement access.

A leak exposed Cellebrite's forensic data extraction vulnerabilities in most Google Pixel phones, except those secured by GrapheneOS.